NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,000 | -17.4% | 229 | +16.8% | 0.00% | -50.0% |
| Q3 2021 | $23,000 | -32.4% | 196 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $34,000 | +21.4% | 204 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | +27.3% | 204 | +59.4% | 0.00% | 0.0% |
| Q4 2020 | $22,000 | +22.2% | 128 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | +20.0% | 128 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | +15.4% | 128 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -13.3% | 128 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $15,000 | +36.4% | 128 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | +175.0% | 128 | +113.3% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 60 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 60 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -40.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |